Sort
21,453 grants matching “tuberculosis”
Inhaled tigecycline therapy for pulmonary M. abscessus infections
$623,786Mercedes Gonzalez-Juarrero · Colorado State University · R01 · FY2025 · AI
Functional dynamics of TB granuloma architecture
$623,757Joel D. Ernst · University Of California, San Francisco · U01 · FY2022 · AI
CRDF GLOBAL WILL PROVIDE FIDUCIARY SUPPORT TO CDC TO MANAGE TB-RELATED ACTIVITIES
$623,693Shawn Trenton Wheeler · U S Civilian Research/ Development Fdn · U01 · FY2013 · PS
Pharmacokinetics of Anti-tuberculosis and Antiretroviral Drugs in Children
$623,600Awewura Jacob Kwara · University Of Florida · R01 · FY2019 · HD
Making Better Decisions: Policy Modeling for AIDS and Drug Abuse
$623,455Douglas K Owens · Stanford University · R01 · FY2016 · DA
TB detection in children using a novel stool-based GeneXpert assay
$623,129David Alland · Rbhs-New Jersey Medical School · R01 · FY2022 · AI
Antigen export in M. tuberculosis evasion of CD4 T cells
$623,115Joel D. Ernst · University Of California, San Francisco · R01 · FY2018 · AI
Predicting tuberculosis outcomes using genotypic and biomarker signatures
$623,092Gillian L Beamer · Tufts University Boston · R01 · FY2021 · HL
Novel Inhibitors to DHPS to Probe Catalytic Mechanism & Therapeutic Potential
$623,075Stephen W White · St. Jude Children'S Research Hospital · R01 · FY2010 · AI
The role of inflammation in driving leukemogenesis in germline predisposition syndromes
$622,915Lucy Ann Godley · Northwestern University At Chicago · U01 · FY2024 · CA
Improved understanding of TB transmission by accounting for within-host heterogeneity of M. tuberculosis: A population-based molecular epidemiology study in a high HIV prevalent setting
$622,902Sanghyuk Sam Shin · University Of California-Irvine · R01 · FY2023 · AI
Chemical Biological Discovery of Lipid Virulence Factors in the Major Bacterial Pathogens
$622,787David Branch Moody · Brigham And Women'S Hospital · R01 · FY2023 · AI
Vaccine and Treatment Evaluation Units: Phase I Clinical Trial to Evaluate TB Therapeutics
$622,751Daniel Hoft · Saint Louis University · N01 · FY2019 · AI
SIngle-saMPLE tuberculosis evaluation to facilitate linkage to care: The SIMPLE TB trial
$622,459Adithya Cattamanchi · University Of California, San Francisco · R01 · FY2020 · HL
Strategies for tuberculosis control in prisons
$622,457Jason Randolph Andrews · Stanford University · R01 · FY2019 · AI
Mechanisms of anti-fungal Vaccine immunity
$622,456Bruce Steven Klein · University Of Wisconsin-Madison · R01 · FY2014 · AI
Treating Sleep Apnea in Type 2 Diabetes Mellitus: A Randomized Clinical Trial
$622,456Naresh Punjabi · Johns Hopkins University · R01 · FY2017 · HL
Interruption of maternal-fetal transmission of HIV
$622,305Joseph M McCune · University Of California, San Francisco · R01 · FY2010 · AI
Adapting and evaluating a brief advice tobacco intervention in high-reach, low-resource settings in India
$622,157Kasisomayajula Viswanath · Dana-Farber Cancer Inst · R01 · FY2022 · CA
Elucidating the path to type I IFNs in TB infection
$622,117Amy K Barczak · Massachusetts General Hospital · R01 · FY2025 · AI
Hollow Fiber Infection Model to Delineate Combination Drug Interaction for Different MTB Metabolic Populations and using Different Pharmacokinetic Profiles
$622,032George Louis Drusano · University Of Florida · P01 · FY2019 · AI
Mechanistic investigation of RNA-mediated gene regulation and immunity
$621,986Ailong Ke · Cornell University · R35 · FY2018 · GM
Optimization Of HIV Specific Immune Responses In Vivo
$621,788Robert A Seder · Niaid Extramural Activities · Z01 · FY2007 · AI
Development Of A Vaccine For Leishmania Major Infection
$621,788Robert A Seder · Niaid Extramural Activities · Z01 · FY2007 · AI
Targeting the casein kinase 1 (CK1)-like kinase Yck2 in fungal pathogenesis
$621,777Leah Elizabeth Cowen · University Of Toronto · R01 · FY2023 · AI